WG Biotech ApS: Financial statements 2022
CVR: 36940131
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
WG Biotech ApS (CVR 36940131) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -302,272,000 and a net result of DKK -300,233,000 compared with DKK -913,860,000 the year before. Equity in the 2022 report amounted to DKK 202,851,000. The solvency ratio was 96.1%.
- Gross Profit
- DKK -302,272,000
- Profit/Loss
- DKK -300,233,000
- Equity
- DKK 202,851,000
- Total Assets
- DKK 211,025,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -302.3 mio. | -300.2 mio. | 202.9 mio. | - |
| 2021 | - | -915.8 mio. | -913.9 mio. | 503.1 mio. | - |
| 2020 | - | - | 502.6 mio. | 1.6 mia. | - |
| 2019 | - | - | 389.5 mio. | 1.1 mia. | - |
| 2018 | - | - | 657.5 mio. | 657 mio. | - |
Official annual report
Keep an eye on WG Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
WG Biotech ApS has published its annual report for 2021. Gross profit came to DKK -915,846,000, and the net result was DKK -913,860,000.
About WG Biotech ApS
WG Biotech ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2015. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Johan Ernst Wedell-Wedellsborg. The company is owned by WECO A/S and WG Biotech ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,963,000 and a net result of DKK 2,166,000 compared with DKK 48,534,000 the year before. Equity in the 2025 report amounted to DKK 311,608,000.